Cardiac Science's Powerheart G3 Plus, a CPR-enhanced addition to the Powerheart automated external defibrillator (AED) platform is designed for the public access defibrillation market in the U.S. and abroad.

The Stereotaxis Magnetic Navigation System is designed to enable physicians to complete complex interventional procedures by using computer-controlled, externally applied magnetic fields that govern the motion of the working tip of the catheter or guide wire.

Procedural benefits include increased precision of catheter movements, improved stability of the cather in difficult locations and computer memory of difficult anatomic locations. Plus, the catheter is very soft, making the perforation risk much lower than normal.

ZOLL Medical Corp. has received FDA clearance to market and sell the ZOLL M Series with Real CPR Help technology. The device enables rescuers to instantly see and hear how well they are performing the rate and depth of CPR chest compressions.
The M Series is the Company’s best-selling product to date. The approval extends Real CPR Help to ZOLL’s complete defibrillator product line.

St. Jude Medical Inc.’s new cardiac rhythm management device is designed to help physicians manage heart failure (HF) patients, including patients who have or may develop atrial fibrillation (AF).

The 6F Luminexx 3 Biliary Stent is the benchmark for self-expanding nitinol stent visibility under fluoroscopy. Radiopaque tantalum markers ensure clear visualization, significantly enhancing deployment and placement accuracy. Luminexx offers an open cell and flexible mesh design with minimal foreshortening.

The PerforMAXX Grip provides maximum performance in stent placement accuracy and control. The ergonomically contoured design achieves optimal balance and lightweight comfort at any angle and allows for one-handed deployment.

May 2007

The AtriCure Ablation and Sensing Unit (ASU) is a device that makes linear and transmural lesions in a matter of seconds. The system can demonstrate when a transmural lesion has been formed by measuring the conductance of soft tissue, and it only takes a few seconds by using its patented method of targeting ablative energy.

The system has the ability to evaluate the conductance of tissue as it is being ablated. This is done 10 times per second — at the very moment that the lesion becomes transmural, or no longer able to conduct energy, the ASU gives a signal.

The Stereotaxis Navistar RMT Dual Sensor magnetically enabled 8mm ablation catheter has received FDA approval and will soon be commercially available in the U.S. The 8mm catheter expands electrophysiology applications for the Stereotaxis Magnetic Navigation system by providing physicians the ability to deliver high power ablations for the treatment of atrial arrhythmias.

Immersion Medical has updated its endovascular platform with features that allow it to simulate a wider range of procedures. The new platform, called the CathLabVR system, allows surgical simulation with as many as four devices or tools and for procedures involving more regions of the body.

In addition to coronary treatments, physicians use endovascular procedures to treat several other diseases, including peripheral arterial disease.

Onset Medical Corp.’s SoloPath transseptal access catheter utilizes Onset's Controlled Deployment Technology (CDT) to allow percutaneous access to the chambers of the left heart and surrounding vasculature.

Sentinel integrates the entire range of noninvasive diagnostic cardiology solutions including ECG Exercise Testing, 12-Lead ECG, Holter Monitoring, ECG Event Recording and Ambulatory Blood Pressure Monitoring into one central data management system.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now